LuciAboz (Cabozantinib) 20mg | Multi-Kinase Inhibitor | Lucius Pharmaceuticals (Lao) Co., Ltd. | GLT

REQUEST A QUOTE

Tap "Request a Quote" to open WhatsApp — the product details are already filled in. Just add your quantity and destination country.

  • We reply within 24 hours with pricing, availability & COA
  • Serves individuals and institutions worldwide

Prefer email? [email protected] · +86 15234153837

Share
Product description

LuciAboz is Lucius Pharmaceuticals' generic cabozantinib, manufactured at the company's facility in Laos. It provides the 20 mg capsule in packs of 90, the lower standard strength of this multi-kinase inhibitor, as an affordable option for patients needing ongoing targeted therapy.

Generic Information: LuciAboz (Cabozantinib)

Lucius Pharmaceuticals (Lao) Co., Ltd. is a specialty pharmaceutical company with a broad portfolio of targeted oncology generics under its "Luci" brand family. LuciAboz is its cabozantinib offering, containing the same active ingredient as the originator Cometriq and Cabometyx, and serving both the Lao home market and a wide export network.

What Is LuciAboz (Cabozantinib) Used For?

LuciAboz treats medullary thyroid cancer, renal cell carcinoma, hepatocellular carcinoma, differentiated thyroid cancer and neuroendocrine tumors. As a generic, it reproduces the originator's clinical indications with the same active molecule.

How Does LuciAboz Work?

The cabozantinib in LuciAboz inhibits MET, VEGFR-2, RET, AXL, KIT and FLT-3, suppressing tumor growth, reducing tumor blood-vessel formation and limiting metastasis. This multi-kinase mechanism is the same as the originator's.

Indications

  • Progressive, metastatic medullary thyroid cancer
  • Advanced renal cell carcinoma
  • Hepatocellular carcinoma after sorafenib
  • Differentiated thyroid cancer refractory to radioactive iodine
  • Well-differentiated neuroendocrine tumors

Dosage & Administration

The 20 mg capsule is one of the two standard strengths used to make up the daily dose, which is 140 mg for medullary thyroid cancer and 60 mg for most other indications. Capsules are swallowed whole with water. Dosing is directed by the physician.

Side Effects

Diarrhea, fatigue, nausea, decreased appetite, hand-foot skin reaction and high blood pressure are common. Serious risks include severe bleeding, gastrointestinal perforation, blood clots, heart problems and osteonecrosis of the jaw. Regular monitoring is part of treatment.

Storage & Handling

Store at room temperature in the original packaging, protected from moisture and light, out of children's reach, and not past expiry.

Why Choose LuciAboz?

  • Lucius generic — a trusted name in Lao oncology generics.
  • 20 mg standard strength — used across the dosing regimens.
  • Cost-effective — lower-priced cabozantinib for ongoing therapy.

How to Order LuciAboz from GLT

  1. Contact GLT via WhatsApp +86 15234153837 or email [email protected].
  2. Receive a quotation and delivery estimate.
  3. Pay via Hao Yi Lian / 好易联.
  4. Dispatch with documentation and tracking.

A valid prescription may be requested before dispatch. Institutions and individual patients are served.

FAQ

1. Who manufactures LuciAboz?

LuciAboz is manufactured by Lucius Pharmaceuticals (Lao) Co., Ltd.

2. Is LuciAboz a generic of Cometriq?

Yes, it is a generic cabozantinib with the same active ingredient.

3. Do I need a prescription?

Yes, cabozantinib is prescription-only.

Related Oncology Products

KeZeRui 科瑞泽 (Avatrombopag) 20mg*10 Tablets | Sichuan Kelun China | GLT

KeZeRui — national-procurement avatrombopag from Sichuan Kelun Pharmaceutical, China's integrated API + tablet maker

Olumiant (Baricitinib) 2mg/4mg Tablets | JAK1/JAK2 Inhibitor | Eli Lilly USA | GLT

Eli Lilly's selective JAK1/JAK2 inhibitor for rheumatoid arthritis, atopic dermatitis and severe alopecia areata.

Tixepa (Tirzepatide) 20mg/2mL & 30mg/2mL Multi-Dose Pen | Drug International | GLT

Tixepa — Drug International Limited (DIL) tirzepatide multi-dose pen, two official strengths (Tixepa-5 = 20mg/2mL,...

Tirzema (Tirzepatide) 2.5/5/7.5mg/0.5mL Single-Dose Pen | Incepta Bangladesh | GLT

Tirzema — Incepta Pharmaceuticals tirzepatide single-dose pen, three official strengths (2.5/5/7.5mg/0.5mL) for T2DM and weight...

Barinib (Baricitinib) 2mg | Generic JAK1/JAK2 Inhibitor | Drug International Limited | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Drug International Limited (Bangladesh) — an affordable alternative to Olumiant...

Palutini (Baricitinib) 4mg | Generic JAK1/JAK2 Inhibitor | Trans Continental Life Science & Pharmaceuticals (TLPH) | GLT

Generic baricitinib (JAK1/JAK2 inhibitor) by Trans Continental Life Science & Pharmaceuticals (TLPH) (Laos) — an...

KangQuXin 康曲欣 (Avatrombopag) 20mg*10 Tablets | Beijing Continent Gyre | GLT

KangQuXin — avatrombopag by Beijing Continent Pharmaceutical (Gyre Therapeutics, Nasdaq: GYRE), China Mainland

AVATODX (Avatrombopag) 20mg*30 Tablets | Bigbear Pharmaceutical Laos | GLT

AVATODX — avatrombopag 20mg by Bigbear Pharmaceutical (Lao) Co., Ltd., Lao Reg. 06L0985/23, 30-tablet bottle